Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tonapofylline in Heart Failure and Renal Insufficiency
NCT00745316Phase 2Terminated
- Sponsor
- Biogen
- Start
- Feb 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tonapofylline in heart failure (HF), Renal Insufficiency (RI), sponsored by Biogen. Started Feb 2009; status: terminated.
02
Drugs
tonapofylline
03
Conditions
heart failure (HF)Renal Insufficiency (RI)
Beyond the preview
Go deeper on NCT00745316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00745316.